BioNexus Gene Lab (BGLC) Asset Utilization Ratio (2019 - 2026)

BioNexus Gene Lab's Asset Utilization Ratio history runs 8 years deep, the most recent figure standing at 0.58 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 37.61% year-over-year to 0.58; the TTM figure through Mar 2026 stood at 0.58 (down 37.61% YoY), while the FY2025 annual figure was 0.75, down 13.42% from the prior year.
• Asset Utilization Ratio came in at 0.58 for Q1 2026 at BioNexus Gene Lab, down from 0.88 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 1.41 in Q2 2022 to a low of 0.58 in Q1 2026.
• A 5-year average of 1.05 and a median of 1.01 in 2025 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio jumped 32.76% in 2025 and tumbled 37.61% in 2026, its largest moves.
• BioNexus Gene Lab's Asset Utilization Ratio stood at 1.32 in 2022, then plunged by 35.33% to 0.85 in 2023, then increased by 3.86% to 0.89 in 2024, then fell by 0.86% to 0.88 in 2025, then plunged by 34.02% to 0.58 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.58, 0.88, and 1.11 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison